Market Tracker

09/27 4:43pm ET

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

0.9074
Delayed Data
As of 3:59pm ET
 +0.014 / +1.57%
Today’s Change
0.26
Today|||52-Week Range
2.40
-31.77%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close0.89
Today’s open0.94
Day’s range0.85 - 0.97
Volume1,130,476
Average volume (3 months)2,030,709
Market cap$139.1M
Dividend yield--
Data as of 3:59pm ET, 09/27/2016

Growth & Valuation

Earnings growth (last year)+25.00%
Earnings growth (this year)+55.56%
Earnings growth (next 5 years)--
Revenue growth (last year)+111.15%
P/E ratioNM
Price/Sales15.18
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ASMBAssembly Biosciences...-0.18-2.21%
TTPHTetraphase Pharmaceu...+0.11+2.86%
XENEXenon Pharmaceutical...+0.03+0.37%
CORICorium International...-0.07-1.17%
Data as of 4:00pm ET, 09/27/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$13.2M
Annual profit (last year)-$27.6M
Net profit margin-213.76%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mike M. Goldberg
Chief Operating &
Financial Officer
Jed Andrew Latkin
Corporate headquarters
Dublin, Ohio

Forecasts